K.C. Pharmaceuticals Expands Eye Drop Recall to Over 3 Million Bottles Due to Sterility Concerns
K.C. Pharmaceuticals, Inc., a California-based company, has expanded its recall of eye drop products to include more than 3 million bottles distributed across major retailers such as Walgreens, CVS, and Rite Aid. The recall, initiated on March 3, was prompted by a lack of assurance of sterility, as noted in an FDA notice. The recall has been classified as a Class II recall, indicating that the use of or exposure to the product may cause temporary or medically reversible adverse health consequences, with a remote probability of serious health consequences. The affected products include various types of eye drops, such as Dry Eye Relief Drops, Artificial Tears Sterile Lubricant Eye Drops, and others. The recall is part of a broader trend of eye drop recalls in recent years, often due to contamination concerns. 
